The primary aim of this discussion paper is to assess the usefulness of the anti-Müllerian hormone assay procedure (AMH) with a view to its inclusion in the NABM (Nomenclature of Procedures in Laboratory Medicine).
See also
HAS opinions and decisions
26/07/2017
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
8xRXgTzHWkddeULQ